MedTrace Logo

Combination Deplin® and Antidepressant Therapy for a Major Depressive Episode (MDE)- a Retrospective Analysis

NCT01001559 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 242

Last updated 2013-12-19

Study results available
· View outcomes & findings →

Summary

This is a retrospective chart review study to determine if Deplin® 7.5mg-15mg combined with an antidepressant is better than an antidepressant alone in adults with major depression.

Conditions

Interventions

DRUG

L-methylfolate

Subjects must have been on their respective therapies for a minimum of 60 days. L-methylfolate dosing was 7.5 mg or 15 mg daily

DRUG

Selective serotonin reuptake inhibitor (SSRI)

Subject must have been on their respective therapy for a minimum of 60 days. Because this was an observational retrospective analysis, dosing of SSRI/SNRI varied on a per patient basis.

DRUG

Serotonin and norepinephrine reuptake inhibitor (SNRI)

Subject must have been on their respective therapy for a minimum of 60 days. Because this was an observational retrospective analysis, dosing of SSRI/SNRI varied on a per patient basis.

Sponsors & Collaborators

  • Red Oak Psychiatry Associates, PA

    collaborator UNKNOWN

  • Baylor Health Care System

    collaborator OTHER

  • Pamlab, Inc.

    lead INDUSTRY

Principal Investigators

  • Lawrence D Ginsberg, MD · Red Oak Psychiatry Associates, PA

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-08-31
Primary Completion
2010-12-31
Completion
2011-06-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01001559 on ClinicalTrials.gov